Analytical Data
-
Gene name
TRBC2
- Application
-
Alternative Names
T cell receptor beta constant 2; TRBC2
-
Species
Human
-
Source
HEK293
-
Tag
C-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0A5B9
-
Expression Region
D1-A144
-
Protein Length
Partial
-
Molecular Weight
19-21 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TRBC2 (T-cell receptor beta constant region 2) is a crucial component of the T-cell receptor (TCR) complex, which plays a vital role in the immune response by recognizing antigens. Research into TRBC2 recombinant protein has gained significant attention due to its potential applications in immunotherapy, vaccine development, and understanding T-cell biology. TCRs are composed of variable and constant regions, with the beta chain being essential for recognizing peptide-MHC complexes presented by antigen-presenting cells. Recombinant TRBC2 protein can provide insights into TCR signaling pathways, enhance T-cell functionality, and facilitate the study of T-cell development and differentiation. Additionally, generating recombinant TRBC2 allows researchers to explore its structural and functional properties, paving the way for novel therapeutic strategies against cancer and infectious diseases. The ability to produce TRBC2 in a laboratory setting also enables the design of TCRs with improved specificity and affinity, which are critical for the success of T-cell therapies. As the field of immunology continues to evolve, understanding the role of TRBC2 and its recombinant forms may lead to advancements in personalized medicine and immune modulation, addressing pressing health challenges.
